BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Results for Bimagrumab in Obesity and Type 2 Diabetes presented by MorphoSys’s Partner

  MorphoSys AG announced that its licensee Novartis presented phase 2 results for bimagrumab, a human anti-activin receptor monoclonal antibody developed by Novartis and generated utilizing MorphoSys’s proprietary HuCAL antibody technology.

  November 12, 2019

   · 

  4 min read
• Carestream Customers Inspire Enhanced Mobile Imaging System

  In response to customer feedback, Carestream has further developed the DRX-Revolution Mobile X-ray System with an improved ergonomic design and user workflow.

  November 12, 2019

   · 

  2 min read
• Business

  Lonza - Board Announcement on 12 November 2019

  Lonza announced that Marc Funk, CEO, will leave the Company for personal reasons. The Board of Directors also announced that Albert Baehny, Chairman, will take on the additional responsibility of Chief Executive Officer on an ad interim basis until a permanent successor is found.

  November 12, 2019

   · 

  3 min read
• 

  Drug Development

  Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation

  SNF472 significantly reduced progression of cardiovascular calcification in patients with end stage kidney disease (ESKD) receiving hemodialysis

  November 12, 2019

   · 

  7 min read
• 

  Policy

  Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia

  Second Orphan Drug Designation granted by the European Commission for leriglitazone, in addition to X-linked adrenoleukodystrophy (X-ALD)

  November 12, 2019

   · 

  4 min read
• 

  Business

  RSSL Named Best CRO at OBN Awards

  Outstanding dedication to quality, science and customer service helped RSSL secure Best Contract Research Organisation at this year’s Oxford Bioscience Network (OBN) Awards.

  November 12, 2019

   · 

  1 min read
• 

  Business

  Europe has a new bioregion: Galicia and Northern Portugal join to collaborate internationally

  The bioregion is from until November 13 participating at the 25th Annual International Partnering Conference BIO-Europe 2019 in Hamburg.

  November 12, 2019

   · 

  3 min read
• Deals

  Actuate Therapeutics Completes $6.5 Million Series B-3 Financing To Expand Clinical Programs

  Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, announced it has raised an additional $6.5M in a Series B-3 financing round.

  November 12, 2019

   · 

  4 min read
• 

  Deals

  AiCuris Provides Corporate Update - November 12, 2019

  Over 15,000 patients worldwide already treated with Letermovir to prevent Cytomegalovirus (CMV) infection and disease in allogeneic stem cell transplantation

  November 12, 2019

   · 

  7 min read
• 

  MolPort Announces Addition of Solubility Information to its Online Chemical Sourcing Database

  Scientists save time and reduce costs by only ordering compounds with suitable solubility; aids screening library selection and sourcing

  November 12, 2019

   · 

  3 min read